Drug Shortage Report for MYLAN-RIVASTIGMINE PATCH 10

Last updated on 2019-07-30 History
Report ID 83413
Drug Identification Number 02423421
Brand name MYLAN-RIVASTIGMINE PATCH 10
Common or Proper name RIVASTIGMINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) RIVASTIGMINE
Strength(s) 18MG
Dosage form(s) PATCH
Route of administration TRANSDERMAL
Packaging size 30 PATCHES
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-06-04
Actual start date 2019-06-04
Estimated end date 2019-07-26
Actual end date 2019-07-29
Shortage status Resolved
Updated date 2019-07-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-05-08 French Compare
v1 2019-05-08 English Compare

Showing 21 to 22 of 22